Taylor Wealth Management Partners’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
GIPM
DCM
AC
Taylor Wealth Management Partners's OPRX Position: Q2 2022 in Review
Taylor Wealth Management Partners sold out of OptimizeRx (OPRX) in Q2 2022, closing a stake of 9,184 shares — an estimated $346K sold.
Taylor Wealth Management Partners first reported a position in OPRX in Q1 2019 and held it in 13 quarters. The position peaked at $1.74M in Q3 2021. 147 funds tracked by Wall St. Rank hold OPRX as of Q2 2022.
- Taylor Wealth Management Partners reported no remaining OptimizeRx position as of Q2 2022 after selling out during the quarter.
- Taylor Wealth Management Partners sold 9,184 OptimizeRx shares in Q2 2022, an estimated $346K.
- Taylor Wealth Management Partners first reported a position in OptimizeRx in Q1 2019 and held it in 13 quarters.
- Taylor Wealth Management Partners's OptimizeRx position peaked at $1.74M in Q3 2021.
- 147 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2022.
Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.